Dachaigh › Carcinoma Epithelial Ovarian › Minnesota

Sgrùdaidhean clionaigeach Carcinoma Epithelial Ovarian ann an Minnesota

Tha 7 sgrùdaidhean airson Carcinoma Epithelial Ovarian a’ lorg phàirtichean aig làraichean ann an Minnesota.

Bailtean ann an Minnesota

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

University of Minnesota - Minneapolis /ID# 275718, Minneapolis
Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT06890338

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Masonic Cancer Center, University of Minnesota, Minneapolis

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 15 Sult 2026 · NCT06915025

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mayo Clinic (Rochester), Rochester

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05059444

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Research Site, Minneapolis

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 21 Iuch 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Minnesota Oncology Hematology PA, Minneapolis

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Iuch 2026 · NCT06819007

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Mayo Clinic, Rochester

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06395519

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
University of Minnesota, Minneapolis
Mayo Clinic, Rochester

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Banairean · Air ùrachadh 23 Dùbh 2025 · NCT06690775

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.